[1]
S. Hamzic, “Fluoropyrimidine chemotherapy: recommendations for DPYD genotyping and therapeutic drug monitoring of the Swiss Group of Pharmacogenomics and Personalised Therapy”, Swiss Med Wkly, vol. 150, no. 4748, p. w20375, Nov. 2020.